{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:50:50Z","timestamp":1789599050133,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The gamma-glutamyl transpeptidase to platelet ratio (GPR) is a novel index to estimate liver fibrosis in chronic hepatitis B (CHB). Few studies compared diagnostic accuracy of GPR with other non-invasive fibrosis tests based on blood parameters. We analyzed diagnostic values of GPR for detecting liver fibrosis and compared diagnostic performances of GPR with APRI (aspartate aminotransferase-to-platelet ratio index), FIB-4 (fibrosis index based on the four factors), NLR (neutrophil-to-lymphocyte ratio), AAR (aspartate aminotransferase\/alanine aminotransferase ratio) and RPR (red cell distribution width-to-platelet ratio) in HBeAg positive CHB and HBeAg negative CHB. We found AUROCs of GPR in predicting significant liver fibrosis, advanced liver fibrosis and liver cirrhosis were 0.732 (95% CI 0.663 to 0.801), 0.788 (95% CI 0.729 to 0.847) and 0.753 (95% CI 0.692 to 0.814), respectively. Further comparisons showed the diagnostic performance of GPR was not significantly different with APRI, FIB-4 and RPR in identifying significant fibrosis, advanced fibrosis and cirrhosis, but it was significantly superior to AAR and NLR in both HBeAg positive CHB and HBeAg negative CHB. In conclusion, GPR does not show advantages than APRI, FIB-4 and RPR in identifying significant liver fibrosis, advanced liver fibrosis and liver cirrhosis in both HBeAg positive CHB and HBeAg negative CHB in China.<\/jats:p>","DOI":"10.1038\/s41598-017-09234-w","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T11:01:27Z","timestamp":1502449287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China"],"prefix":"10.1038","volume":"7","author":[{"given":"Rui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"9234_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"Y-F Liaw","year":"2009","unstructured":"Liaw, Y.-F. & Chu, C.-M. Hepatitis B virus infection. Lancet. \n                           373, 582\u2013592, doi:10.1016\/S0140-6736(09)60207-5 (2009).","journal-title":"Lancet."},{"key":"9234_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po, C., Chan, H. L. Y. & Lok, A. Hepatitis B virus infection. Lancet. \n                           384, 2053\u20132063, doi:10.1016\/S0140-6736(14)60220-8 (2014).","journal-title":"Lancet."},{"key":"9234_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","volume":"11","author":"G Shiha","year":"2016","unstructured":"Shiha, G. et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol. Int. \n                           11, 1\u201330, doi:10.1007\/s12072-016-9760-3 (2016).","journal-title":"Hepatol. Int."},{"key":"9234_CR4","doi-asserted-by":"crossref","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology \n                           20, 15\u201320, doi:10.1002\/hep.1840200104 (1994).","DOI":"10.1002\/hep.1840200104"},{"key":"9234_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/jhep.2000.16602","volume":"32","author":"JF Cadranel","year":"2000","unstructured":"Cadranel, J. F., Rufat, P. & Degos, F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology \n                           32, 477\u2013481, doi:10.1053\/jhep.2000.16602 (2000).","journal-title":"Hepatology"},{"key":"9234_CR6","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev, A. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. \n                           97, 2614\u20132618, doi:10.1111\/j.1572-0241.2002.06038.x (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"9234_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/liv.12628","volume":"35","author":"JH Kim","year":"2015","unstructured":"Kim, J. H., Kim, M. N., Han, K.-H. & Kim, S. U. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. Liver Int. \n                           35, 1103\u20131115, doi:10.1111\/liv.12628 (2015).","journal-title":"Liver Int."},{"key":"9234_CR8","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1111\/liv.12808","volume":"35","author":"YS Seo","year":"2015","unstructured":"Seo, Y. S. et al. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int. \n                           35, 2246\u20132255, doi:10.1111\/liv.12808 (2015).","journal-title":"Liver Int."},{"key":"9234_CR9","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.22577","volume":"48","author":"G Millonig","year":"2008","unstructured":"Millonig, G. et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology \n                           48, 1718\u20131723, doi:10.1002\/hep.22577 (2008).","journal-title":"Hepatology"},{"key":"9234_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1478-3231.2008.01894.x","volume":"29","author":"SU Kim","year":"2009","unstructured":"Kim, S. U. et al. Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis. Liver Int. \n                           29, 810\u2013815, doi:10.1111\/j.1478-3231.2008.01894.x (2009).","journal-title":"Liver Int."},{"key":"9234_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ajg.2010.463","volume":"106","author":"J Fung","year":"2011","unstructured":"Fung, J. et al. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am. J. Gastroenterol. \n                           106, 492\u2013496, doi:10.1038\/ajg.2010.463 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"9234_CR12","unstructured":"World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection (2015)."},{"key":"9234_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hep.27382","volume":"61","author":"G Xiao","year":"2015","unstructured":"Xiao, G., Yang, J. & Yan, L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology \n                           61, 292\u2013302, doi:10.1002\/hep.27382 (2015).","journal-title":"Hepatology"},{"key":"9234_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","volume":"64","author":"WR Kim","year":"2016","unstructured":"Kim, W. R. et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J. Hepatol. \n                           64, 773\u2013780, doi:10.1016\/j.jhep.2015.11.012 (2016).","journal-title":"J. Hepatol."},{"key":"9234_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","volume":"65","author":"M Lemoine","year":"2016","unstructured":"Lemoine, M. et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut \n                           65, 1369\u20131376, doi:10.1136\/gutjnl-2015-309260 (2016).","journal-title":"Gut"},{"key":"9234_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003372","volume":"95","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China. Medicine \n                           95, e3372, doi:10.1097\/MD.0000000000003372 (2016).","journal-title":"Medicine"},{"key":"9234_CR17","doi-asserted-by":"publisher","unstructured":"Schiavon, L. L., Narciso-Schiavon, J. L., Ferraz, M. L. G., Silva, A. E. B. & Carvalho-Filho, R. J. The \u03b3-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up? Gut. doi:10.1136\/gutjnl-2016-312658 (2016).","DOI":"10.1136\/gutjnl-2016-312658"},{"key":"9234_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068780","volume":"8","author":"B Chen","year":"2013","unstructured":"Chen, B., Ye, B., Zhang, J., Ying, L. & Chen, Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PloS One \n                           8, e68780, doi:10.1371\/journal.pone.0068780 (2013).","journal-title":"PloS One"},{"key":"9234_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/jvh.12279","volume":"21","author":"E Teshale","year":"2014","unstructured":"Teshale, E. et al. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J. Viral Hepat. \n                           21, 917\u2013920, doi:10.1111\/jvh.12279 (2014).","journal-title":"J. Viral Hepat."},{"key":"9234_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13393","author":"H Desalegn","year":"2017","unstructured":"Desalegn, H., Aberra, H., Berhe, N., Gundersen, S. G. & Johannessen, A. Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa? Liver Int. doi:10.1111\/liv.13393 (2017).","journal-title":"Liver Int."},{"key":"9234_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.dld.2007.10.011","volume":"40","author":"WG Shin","year":"2008","unstructured":"Shin, W. G. et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig. Liver Dis. \n                           40, 267\u2013274, doi:10.1016\/j.dld.2007.10.011 (2008).","journal-title":"Dig. Liver Dis."},{"key":"9234_CR22","doi-asserted-by":"publisher","unstructured":"Lemoine, M., Thursz, M., Mallet, V. & Shimakawa, Y. Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference. Gut doi:10.1136\/gutjnl-2016-311554 (2016).","DOI":"10.1136\/gutjnl-2016-311554"},{"key":"9234_CR23","doi-asserted-by":"publisher","unstructured":"Zhu, M.-Y. et al. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection. J. Viral Hepat., doi:10.1111\/jvh.12682 (2017).","DOI":"10.1111\/jvh.12682"},{"key":"9234_CR24","doi-asserted-by":"publisher","unstructured":"Cai, Y.-J. et al. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. J. Viral Hepat., doi:10.1111\/jvh.12715 (2017).","DOI":"10.1111\/jvh.12715"},{"key":"9234_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/MEG.0000000000000468","volume":"27","author":"AT Eminler","year":"2015","unstructured":"Eminler, A. T. et al. AST\/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur. J. Gastroenterol. Hepatol. \n                           27, 1361\u20131366, doi:10.1097\/MEG.0000000000000468 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"9234_CR26","first-page":"1459","volume":"56","author":"R Vardar","year":"2009","unstructured":"Vardar, R. et al. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology. \n                           56, 1459\u20131465 (2009).","journal-title":"Hepatogastroenterology."},{"key":"9234_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000612","volume":"94","author":"W-S Xu","year":"2015","unstructured":"Xu, W.-S. et al. Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B. Medicine \n                           94, e612, doi:10.1097\/MD.0000000000000612 (2015).","journal-title":"Medicine"},{"key":"9234_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s12072-015-9638-9","volume":"9","author":"A Taefi","year":"2015","unstructured":"Taefi, A., Huang, C.-C., Kolli, K., Ebrahimi, S. & Patel, M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol. Int. \n                           9, 454\u2013460, doi:10.1007\/s12072-015-9638-9 (2015).","journal-title":"Hepatol. Int."},{"key":"9234_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology \n                           24, 289\u2013293, doi:10.1002\/hep.510240201 (1996).","journal-title":"Hepatology"},{"key":"9234_CR30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/archinte.163.2.218","volume":"163","author":"E Giannini","year":"2003","unstructured":"Giannini, E. et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch. Intern. Med. \n                           163, 218\u2013224, doi:10.1001\/archinte.163.2.218 (2003).","journal-title":"Arch. Intern. Med."},{"key":"9234_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/MEG.0b013e32835c2af3","volume":"25","author":"M Biyik","year":"2013","unstructured":"Biyik, M. et al. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur. J. Gastroenterol. Hepatol. \n                           25, 435\u2013441, doi:10.1097\/MEG.0b013e32835c2af3 (2013).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"9234_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1478-3231.2011.02639.x","volume":"32","author":"N Alkhouri","year":"2012","unstructured":"Alkhouri, N. et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. \n                           32, 297\u2013302, doi:10.1111\/j.1478-3231.2011.02639.x (2012).","journal-title":"Liver Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09234-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09234-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:44:40Z","timestamp":1671785080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-09234-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["9234"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-09234-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"18 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8543"}}